Gritstone bio Inc (NASDAQ:GRTS)
| 1.30 Delayed Data As of Nov 28 |  -0.06 / -4.41%Today’s Change | 1.14 Today|||52-Week Range 4.05 | -62.32% Year-to-Date |
Latest GRTS News | Press Releases
No recent news for Gritstone bio Inc.
Today’s Trading
| Previous close | 1.36 |
| Today’s open | 1.33 |
| Day’s range | 1.30 - 1.38 |
| Volume | 66,828 |
| Average volume (3 months) | 1,789,978 |
| Market cap | $129.7M |
Data as of 3:59pm ET, 11/28/2023
Growth & Valuation
| Earnings growth (last year) | -38.31% |
| Earnings growth (this year) | +1.52% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -80.16% |
| P/E ratio | NM |
| Price/Sales | 33.84 |
| Price/Book | 0.69 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AQSTAquestive Therapeuti... | +0.19 | +9.79% |
| ---- | ||
| OMEROmeros Corp | +0.05 | +2.49% |
| CTXRCitius Pharmaceutica... | -0.01 | -1.75% |
Data as of 3:59pm ET, 11/28/2023
Financials
| Next reporting date | March 7, 2024 |
| EPS forecast (this quarter) | -$0.32 |
| Annual revenue (last year) | $9.3M |
| Annual profit (last year) | -$119.7M |
| Net profit margin | -1,291.26% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Emeryville, California |
Forecasts
